CDH11 and osteosarcoma: A multivariate analysis performed on 90 osteosarcomas and 20 osteochondromas, indicated the clinical stage, metastasis status, and the relationship between the expression of CD44V6, CDH11, and β-catenin correlated with improved outcome (172).